<p>Clay B. Siegall, President and CEO of Immunome Inc., reported the acquisition of common shares of Immunome Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001167496-25-000006), on December 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

IMNM

<p>Immunome CEO Clay B. Siegall reported acquiring common shares of Immunome Inc. The original filing is available via EDGAR, the SEC's system. This AI-generated news brief is for informational purposes only and not financial advice.</p>

Immunome CEO Clay B. Siegall Reports Acquisition of Common Shares